AroCell Future Growth
Future criteria checks 2/6
AroCell is forecast to grow earnings and revenue by 28.7% and 27.2% per annum respectively. EPS is expected to grow by 42.3% per annum. Return on equity is forecast to be -32% in 3 years.
Key information
28.7%
Earnings growth rate
42.3%
EPS growth rate
Life Sciences earnings growth | 44.8% |
Revenue growth rate | 27.2% |
Future return on equity | -32.0% |
Analyst coverage | Low |
Last updated | 23 Feb 2024 |
Recent future growth updates
Recent updates
Is Now The Time To Look At Buying AroCell AB (publ) (STO:AROC)?
Apr 20Estimating The Intrinsic Value Of AroCell AB (publ) (STO:AROC)
Feb 27At kr0.45, Is AroCell AB (publ) (STO:AROC) Worth Looking At Closely?
Nov 07We Think AroCell (STO:AROC) Can Afford To Drive Business Growth
Aug 10AroCell (STO:AROC) Is In A Good Position To Deliver On Growth Plans
Apr 18We're Hopeful That AroCell (STO:AROC) Will Use Its Cash Wisely
Jan 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 107 | N/A | N/A | N/A | 1 |
12/31/2025 | 82 | -32 | 2 | 7 | 1 |
12/31/2024 | 61 | -51 | -12 | -7 | 1 |
12/31/2023 | 43 | -59 | -15 | -13 | N/A |
9/30/2023 | 46 | -59 | -19 | -15 | N/A |
6/30/2023 | 46 | -57 | -15 | -11 | N/A |
3/31/2023 | 40 | -57 | -14 | -10 | N/A |
12/31/2022 | 37 | -59 | -18 | -14 | N/A |
9/30/2022 | 30 | -62 | -21 | -21 | N/A |
6/30/2022 | 26 | -69 | -27 | -26 | N/A |
3/31/2022 | 20 | -59 | -30 | -30 | N/A |
12/31/2021 | 12 | -50 | -29 | -28 | N/A |
9/30/2021 | 6 | -36 | -23 | -23 | N/A |
6/30/2021 | 0 | -25 | -21 | -21 | N/A |
3/31/2021 | 0 | -25 | -20 | -20 | N/A |
12/31/2020 | 0 | -24 | -19 | -19 | N/A |
9/30/2020 | 0 | -24 | -19 | -19 | N/A |
6/30/2020 | 0 | -22 | -16 | -16 | N/A |
3/31/2020 | 0 | -21 | -16 | -16 | N/A |
12/31/2019 | 0 | -21 | -15 | -15 | N/A |
9/30/2019 | 0 | -20 | -16 | -16 | N/A |
6/30/2019 | 0 | -21 | -18 | -18 | N/A |
3/31/2019 | 1 | -22 | -18 | -18 | N/A |
12/31/2018 | 1 | -21 | -16 | -16 | N/A |
9/30/2018 | 1 | -21 | -15 | -15 | N/A |
6/30/2018 | 1 | -19 | -15 | -14 | N/A |
3/31/2018 | 0 | -17 | -14 | -13 | N/A |
12/31/2017 | 1 | -17 | -16 | -15 | N/A |
9/30/2017 | 0 | -13 | N/A | -16 | N/A |
6/30/2017 | 0 | -12 | N/A | -13 | N/A |
3/31/2017 | 0 | -11 | N/A | -11 | N/A |
12/31/2016 | 0 | -9 | N/A | -7 | N/A |
9/30/2016 | 1 | -9 | N/A | -8 | N/A |
6/30/2016 | 0 | -8 | N/A | -8 | N/A |
3/31/2016 | 0 | -8 | N/A | -7 | N/A |
12/31/2015 | 0 | -7 | N/A | -9 | N/A |
9/30/2015 | N/A | -9 | N/A | N/A | N/A |
6/30/2015 | N/A | -8 | N/A | N/A | N/A |
3/31/2015 | N/A | -8 | N/A | N/A | N/A |
12/31/2014 | N/A | -6 | N/A | N/A | N/A |
9/30/2014 | N/A | -5 | N/A | N/A | N/A |
6/30/2014 | N/A | -5 | N/A | N/A | N/A |
3/31/2014 | N/A | -4 | N/A | N/A | N/A |
12/31/2013 | N/A | -4 | N/A | N/A | N/A |
9/30/2013 | N/A | -3 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AROC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AROC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AROC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AROC's revenue (27.2% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: AROC's revenue (27.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AROC is forecast to be unprofitable in 3 years.